Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Capital/Financing Update 2025

Oct 28, 2025

1643_rns_2025-10-28_63048990-f096-4871-b7d2-a8e1885685b3.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

FWP 1 d88040dfwp.htm FWP FWP

Filed pursuant to Rule 433

Registration Statement No. 333-278506

Sanofi

Pricing Term Sheet for the 2032 Fixed Rate Notes

U.S.$1,200,000,000 4.200% Notes due 2032 (the “2032 Fixed Rate Notes”)

Issuer Sanofi
Format SEC-registered global notes
Title 4.200% Notes due 2032 (the “2032 Fixed Rate Notes”)
Principal U.S.$1,200,000,000
Issue Price 99.790% plus accrued interest, if any, from November 3, 2025
Pricing Date October 27, 2025
Expected Settlement Date November 3, 2025 (T+5)
Maturity Date November 3, 2032
Day Count 30/360
Day Count Convention Following unadjusted
Optional Redemption Make-whole call at Treasury Rate plus 10 bps before September 3, 2032
Par call at 100% principal amount on or after September 3, 2032
Tax Redemption Applicable
Ranking Unsecured and unsubordinated
Interest Rate 4.200% per annum
Benchmark Treasury 3.875% due September 30, 2032
Benchmark Treasury Price 100-17 1/4
Benchmark Treasury Yield 3.785%
Spread to Benchmark Treasury +45bps
Yield to Maturity 4.235%
Date Interest Starts Accruing November 3, 2025
Interest Payment Dates Each November 3 and May 3, commencing May 3, 2026
Regular record dates for interest Each October 19 and April 18
Trustee Deutsche Bank Trust Company Americas
Listing None
Denominations U.S.$2,000 and increments of U.S.$1,000 above that amount
Expected Ratings of the Notes* Moody’s: Aa3/Stable
Standard & Poor’s: AA/Stable
Scope Ratings: AA/Stable
CUSIP/ISIN 801060 AJ3 / US801060AJ31
Global Coordinators and Joint Book-Running Managers Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc.
Joint Book-Running Managers J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., Natixis Securities Americas LLC
  • A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

It is expected that delivery of the notes will be made against payment on November 3, 2025 (such settlement being referred to as “T+5”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes prior to one business day before delivery of the notes hereunder will be required, by virtue of the fact that the notes initially settle in T+5, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior their date of delivery hereunder should consult their advisors.

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies may be obtained from Barclays Capital Inc. toll-free at 1-888-603-5847, BNP Paribas Securities Corp. toll-free at 1-800-854-5674 and BofA Securities, Inc. toll-free at 1-800-294-1322.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.